Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354010 · ClinicalTrials.gov registry record
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
A clinical trial of Sensorineural Hearing Loss, Bilateral, sponsored by Sensorion.
- Recruiting
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT06354010: Recruiting study of Sensorineural Hearing Loss, Bilateral, sponsored by Sensorion.
NCT06354010 is a study of Sensorineural Hearing Loss, Bilateral that is actively recruiting participants, run by Sensorion. The registered enrollment target is 100 participants, above the 83-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (20% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06354010, a study of Sensorineural Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Sensorion.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
Primary Outcome
Evolution of hearing impairment assessed by Pure Tone Audiometry
Conditions Studied
Interventions
- GENETIC Genotyping
- OTHER Audiological assessments
Study Locations (2)
Florida
- The University of South Florida Board of Trustees - Tampa
Other
- CHU Gui de Chauliac - Montpellier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2027-07 |
What NCT06354010 shows while recruiting
NCT06354010 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Sensorineural Hearing Loss, Bilateral appearing as the primary indexed condition, and to 2 interventions - of which Genotyping is the first listed.
NCT06354010 reports a single indexed study location in Florida, Other.
Frequently Asked Questions
What is clinical trial NCT06354010 about?
NCT06354010 is a clinical study titled "Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis". The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
What is the current status of trial NCT06354010?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-06-14. Estimated completion is 2027-07.
What conditions does trial NCT06354010 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral.
What interventions are being tested in trial NCT06354010?
The interventions under investigation include: Genotyping (GENETIC), Audiological assessments (OTHER).
Who is sponsoring clinical trial NCT06354010?
This trial is sponsored by Sensorion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354010 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss, Bilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Otoferlin Gene-mediated Hearing Loss Natural History Study
RECRUITING
-
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
RECRUITING · Phase 1
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI